Evidence map›Paper›PMID 22576356›Full record

ReviewTopics in current chemistry2013

Allostery in the Hsp70 chaperone proteins.

Erik R P Zuiderweg, Eric B Bertelsen, Aikaterini Rousaki, Matthias P Mayer, Jason E Gestwicki, Atta Ahmad

Open access · greenAbstract readReview
In one paragraph

Review in Topics in current chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
31.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 160 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Effect of evolution of the C-terminal region on chaperone activity of Hsp70.Protein science : a publication of the Protein Society · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Erik R P ZuiderwegDepartment of Biological Chemistry, The University of Michigan, Ann Arbor, MI 48109, USA. zuiderwe@umich.edu
Eric B Bertelsen
Aikaterini Rousaki
Matthias P Mayer
Jason E Gestwicki
Atta Ahmad
University of Michigan–Ann Arbor · USHeidelberg University · DEMichigan Medicine · US

Funding

Molecular Chaperones and Small MoleculesR01NS059690 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jason E Gestwicki · 2008 to 2026
$7.9M
Study of Allosteric Proteins by NMRR01GM063027 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZUIDERWEG, ERIK R · 2001 to 2010
$2.8M
NIGMS NIH HHS GM63027-S02NIGMS NIH HHS R01 GM063027NINDS NIH HHS NS059690NINDS NIH HHS R01 NS059690
6 · The paper itself

Abstract

Heat shock 70-kDa (Hsp70) chaperones are essential to in vivo protein folding, protein transport, and protein re-folding. They carry out these activities using repeated cycles of binding and release of client proteins. This process is under allosteric control of nucleotide binding and hydrolysis. X-ray crystallography, NMR spectroscopy, and other biophysical techniques have contributed much to the understanding of the allosteric mechanism linking these activities and the effect of co-chaperones on this mechanism. In this chapter these findings are critically reviewed. Studies on the allosteric mechanisms of Hsp70 have gained enhanced urgency, as recent studies have implicated this chaperone as a potential drug target in diseases such as Alzheimer's and cancer. Recent approaches to combat these diseases through interference with the Hsp70 allosteric mechanism are discussed.

Indexed as

Adenosine TriphosphateAllosteric RegulationCrystallography, X-RayHSP70 Heat-Shock ProteinsHydrolysisModels, MolecularAdenosine TriphosphateHSP70 Heat-Shock Proteins

Identifiers

PMID22576356
PMCPMC3623542
OpenAlexW1492302030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.